World Orchestra BioMed’s AVIM Therapy Shows Promise for Heart Disease Orchestra BioMed Holdings, Inc. has released significant clinical findings indicating that its atrioventricular interval modulation (AVIM) therapy could markedly enhance heart function in patients... Editorial9 hours ago